Pancreatic Cancer Research

ResearcherMedical University of South CarolinaNo recent work listed

David T. Marshall

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6029-1538; OpenAlex author ID A5059099227. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 2 papers

Papers 3

  1. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectab… Last author DOI 10.1016/j.ijrobp.2013.12.030↗
  2. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Last author DOI 10.1097/coc.0b013e31826e0570↗
  3. Comparison of radiation treatment delivery for pancreatic cancer: Linac intensity-modulated radiotherapy versus helical tomotherapy. Last author DOI 10.1111/j.1754-9485.2012.02373.x↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Krisha J. Opfermann · 2 shared papers, 2012–2014 · strength 0.08
  2. Ravi Shridhar · 1 shared paper, 2014 · strength 0.05
  3. David J. Cole · 1 shared paper, 2014 · strength 0.04
  4. Ernest Ramsay Camp · 1 shared paper, 2014 · strength 0.04
  5. Nestor F. Esnaola · 1 shared paper, 2014 · strength 0.04
  6. Alberto J. Montero · 1 shared paper, 2014 · strength 0.04
  7. Paul E. O’Brien · 1 shared paper, 2014 · strength 0.04
  8. Robert Taylor · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.